Innovation Dynamics in Biotechnology Firms

Innovation in biotechnology firms is characterised by intensive research and development, complex collaborations and rapid translation of scientific discovery into commercial applications. Firms navigate a dual challenge of advancing basic research while managing intellectual property, regulatory compliance and market demands. Collaborative networks—linking universities, public research bodies and industry partners—serve as critical conduits for knowledge exchange. At the same time, internal capabilities such as absorptive capacity and strategic publishing decisions determine how effectively external discoveries are assimilated and converted into proprietary technologies. Across global markets, biotechnology firms leverage open-innovation models to accelerate drug discovery, improve process efficiencies and respond to public health needs, all while balancing risk, cost and competitive pressures. The practical implications extend from enhanced therapeutic pipelines to strengthened regional innovation ecosystems, underlining the sector’s pivotal role in economic growth and societal welfare.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Innovation Dynamics in Biotechnology Firms publication trend

The graph below shows the total number of articles in innovation dynamics in biotechnology firms across all publications each year (not limited to Nature Index journals).

Technical terms

Open innovation: A model in which firms purposively use external ideas and internal paths to market to advance technology.

Absorptive capacity: The ability of an organisation to recognise, assimilate and apply external knowledge for commercial ends.

Knowledge spillover: Unintended leakage of proprietary knowledge from one entity to others, often through publications or collaborations.

Basic research: Experimental or theoretical work undertaken primarily to acquire new knowledge without immediate commercial objectives.

Translational research: The process of applying discoveries from basic science to develop new therapies, products or technologies.

References

1. When publications lead to products: The open science conundrum in new product development. Research Policy (2014).
2. Public–private contribution to biopharmaceutical discoveries: a bibliometric analysis of biomedical research in UK. Scientometrics (2020).
3. Absorptive capacity for science-based innovation propensity: an empirical analysis using Japanese National Innovation Survey. The Journal of Technology Transfer (2024).